We describe a case of essential thrombocythemia in a 34-year-old male who presented with acute anterior wall myocardial infarction and a platelet count of 2,100,000/mm 3 . Primary percutaneous coronary angioplasty and stenting were performed. Postangioplasty course was complicated by stent thrombosi
Left main coronary thrombosis with essential thrombocythemia
β Scribed by Zekeriya Nurkalem; Nevzat Uslu; Sevket Gorgulu; Mehmet Eren
- Publisher
- Springer US
- Year
- 2006
- Tongue
- English
- Weight
- 176 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0929-5305
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Recent advances permit the detection of activated piatelets using specific monoclonal antibodies and flow cytometry. Nevertheless, there are few reports in which activated platelets have been studied over a period of time in patients at risk for thrombosis. Our patient S.D. has essential thrombocyth
## Abstract ## BACKGROUND There is currently insufficient evidence to either support or refute an association between estrogenβbased hormone treatment (EBHT) and thrombosis risk in essential thrombocythemia (ET). ## METHODS A retrospective review of thrombotic events, which occurred both at diag
## Abstract Background: There is a paucity of data on outcomes in patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) caused by left main stem (LMS) thrombosis. Objectives: We sought to determine (i) the clinical features, (ii) correlates of early mort